Braskem CEO Denies Plans to Sell U.S. Assets
Braskem's CEO stated that the company has no intention of selling its U.S. operations, dismissing reports of potential acquisition talks.
Stocks · News reference
HSBC analyst Sriharsha Pappu downgrades Braskem (NYSE:BAK) from Buy to Hold and lowers the price target from $6.5 to $1.5.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Braskem's CEO stated that the company has no intention of selling its U.S. operations, dismissing reports of potential acquisition talks.
Braskem released its third-quarter 2026 operational data for its Brazilian segment, reporting an 18% decline in sales volume for main petrochemical products and a 9% increase in resin sales volume.
Braskem S.A. is reportedly making progress on a deal to restructure approximately $11 billion in debt, potentially involving a significant capital injection.
U.S. stock futures rose, while Goosehead fell after a downgrade; NFT, Armada and other stocks also slid in premarket trading.
Analysts downgraded PepsiCo, RLJ Lodging Trust, Braskem.